Is Dalargin FDA approved?

Dalargin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Oxytocin FDA approved?

Oxytocin is FDA approved (FDA status current as of 1980-07-09). This regulatory status is provided for research and educational context only.

How is Dalargin administered in research settings?

In research settings, Dalargin is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

How is Oxytocin administered in research settings?

In research settings, Oxytocin is typically administered via the intranasal, subcutaneous, or intravenous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Dalargin vs Oxytocin

Peptide Comparison

Dalargin vs Oxytocin

Name: Dalargin vs Oxytocin — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Neuro & Cognitive peptides.

Dalargin

Leu-enkephalin-Arg

RecoveryNot EvaluatedResearch Only

No providers listed yet

Full Dalargin profile →

Oxytocin

RecoveryFDA ApprovedPrescription

Half-life: ~3-5 minutes (plasma); longer CNS effects

68 providers listed

Full Oxytocin profile →

Bottom line

Oxytocin is FDA-approved, while Dalargin is not evaluated — the clearest structural difference between them.

Quick Verdict

Dalargin

Evidence

Preclinical

Half-life

—

Oxytocin

Evidence

Established Clinical

Half-life

~3-5 minutes (plasma); longer CNS effects

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Oxytocin
Further along in FDA review	Oxytocin
More provider options (0 vs 68)	Oxytocin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Dalargin

Oxytocin

Mechanism Family

Neuro & Cognitive

Half-life

—

~3-5 minutes (plasma); longer CNS effects

FDA Status

not evaluated

approved

Admin Routes

subcutaneous, intravenous

intranasal, subcutaneous, intravenous

Availability

Research Only

Prescription

Providers

None listed

68 listed

FDA Update

—

Jul 1980

Avail. Notes

—

FDA-approved oxytocic hormone. Brand: Pitocin (NDA 016992 and generics). Indicated for labor induction and postpartum hemorrhage. As an approved drug it is compounded via the approved-drug / USP-monograph route; its bulk substance appears on the FDA 503B outsourcing-facility list, not the 503A pharmacy bulk-substances list. Prescription only.

Research Evidence

Dalargin

PreclinicalAnimal · 1 key study · dated evidence base — most recent 2009

Oxytocin

Established ClinicalRCT · 16 key studies · most recent 2026

Research Citations

Dalargin

Animal2009 · Bulletin of Experimental Biology and Medicine

Gastroprotective effect of dalargin in gastropathy due to treatment with nonsteroid antiinflammatory drugs

Oxytocin

Review2023 · Am J Obstet Gynecol

Oxytocin: physiology, pharmacology, and clinical application for labor management

RCT2005 · Nature

Oxytocin increases trust in humans

Cohort2026 · ACS Chem Biol

Metal- and Redox-Dependent Oxytocin Species Differentially Regulate Invasion and Migration in Triple-Negative…

Cohort2026 · Psychiatry Res

Promoting self-compassion meditation with intranasal oxytocin in borderline personality disorder: a pilot stu…

+12 more

About Dalargin

Binds delta and mu opioid receptors with peripheral preference due to limited CNS penetration. Reduces gastric acid secretion, promotes mucosal blood flow, and inhibits ulcer formation via prostaglandin-mediated pathways.

Research Areas

gastroprotectionGI repairanti-ulcerpain modulation

About Oxytocin

Neuropeptide hormone binding oxytocin receptors throughout brain and body; modulates HPA axis, reduces cortisol, promotes parasympathetic tone

Research Areas

prosocial and trust behavior — landmark RCT evidence in humanssocial recognition, attachment, and fear circuit modulationFDA-approved obstetric use (Pitocin) — labor initiation and postpartum hemorrhageinvestigational intranasal 20–40 IU protocols for ASD, PTSD, and social anxiety research

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Dalargin

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Oxytocin

Reported (Unverified — Pending Clinical Review)

cardiovascular diseasehyponatremia risk

No established clinical contraindications

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Used Together?

Oxytocin

PT-141
Research suggests PT-141 and Oxytocin may produce complementary sexual health effects when combined. PT-141 activates central melanocortin receptors involved in arousal signaling, while oxytocin modulates bonding, reward, and peripheral reproductive pathways.

Price (per mg)

Dalargin

Not enough vendor pricing yet.

Oxytocin

$6.00/mg

$4.25 – $12.99 range

23 vendors

View price index →Find providers →

Find Providers

Where to source these peptides

Providers offering

Dalargin

Browse directory →

Providers offering

Oxytocin

68 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 20, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Dalargin vs Oxytocin — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/dalargin/oxytocin

https://peptidebase.io/peptides/compare/dalargin/oxytocin Methodology License Download JSON Download CSV